<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
	<title>pubmed: "nabeshima k"</title>
	<link>https://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&amp;db=PubMed&amp;term=%22Nabeshima%20K%22%5BAuthor%5D</link>
	<description>NCBI: db=pubmed; Term="Nabeshima K"[Author]</description>
	<language>en-us</language>
	<docs>http://blogs.law.harvard.edu/tech/rss</docs>
	<ttl>1440</ttl>
	<image>
		<title>NCBI pubmed</title>
		<url>https://www.ncbi.nlm.nih.gov/entrez/query/static/gifs/iconsml.gif</url>
		<link>https://www.ncbi.nlm.nih.gov/sites/entrez</link>
		<description>PubMed comprises more than millions of citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.</description>
	</image>
<item>
    <title>Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases.</title>         
    <link>https://www.ncbi.nlm.nih.gov/pubmed/33060816?dopt=Abstract</link>    
    <description>
	<![CDATA[<table border="0" width="100%"><tr><td align="left"/></tr></table>
        <p><b>Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases.</b></p>          
        <p>Mod Pathol. 2020 Oct 15;:</p>
        <p>Authors:  Chapel DB, Schulte JJ, Absenger G, Attanoos R, Brcic L, Butnor KJ, Chirieac L, Churg A, Galateau-Sallé F, Hiroshima K, Hung YP, Kindler H, Krausz T, Marchevsky A, Mino-Kenudson M, Mueller J, Nabeshima K, Turaga K, Walts AE, Husain AN</p>
        <p>Abstract<br/>
        Malignant peritoneal mesothelioma historically carried a grim prognosis, but outcomes have improved substantially in recent decades. The prognostic significance of clinical, morphologic, and immunophenotypic features remains ill-defined. This multi-institutional cohort comprises 225 malignant peritoneal mesotheliomas, which were assessed for 21 clinical, morphologic, and immunohistochemical parameters. For epithelioid mesotheliomas, combining nuclear pleomorphism and mitotic index yielded a composite nuclear grade, using a previously standardized grading system. Correlation of clinical, morphologic, and immunohistochemical parameters with overall and disease-free survival was examined by univariate and multivariate analyses. On univariate analysis, longer overall survival was significantly associated with diagnosis after 2000 (P = 0.0001), age &lt;60 years (P = 0.0001), ECOG performance status 0 or 1 (P = 0.01), absence of radiographic lymph-node metastasis (P = 0.04), cytoreduction surgery (P &lt; 0.0001), hyperthermic intraperitoneal chemotherapy (P = 0.0001), peritoneal carcinomatosis index &lt;27 (P = 0.01), absence of necrosis (P = 0.007), and epithelioid histotype (P &lt; 0.0001). Among epithelioid malignant mesotheliomas only, longer overall survival was further associated with female sex (P = 0.03), tubulopapillary architecture (P = 0.005), low nuclear pleomorphism (P &lt; 0.0001), low mitotic index (P = 0.0007), and low composite nuclear grade (P &lt; 0.0001). On multivariate analyses, the low composite nuclear grade was independently associated with longer overall and disease-free survival (P &lt; 0.0001). Our data further clarify the interactions of clinical and pathologic features in peritoneal mesothelioma prognosis and validate the prognostic significance of a standardized nuclear-grading system in epithelioid malignant mesothelioma of the peritoneum.<br/>
        </p><p>PMID: 33060816 [PubMed - as supplied by publisher]</p>
    ]]></description>
    <author> Chapel DB, Schulte JJ, Absenger G, Attanoos R, Brcic L, Butnor KJ, Chirieac L, Churg A, Galateau-Sallé F, Hiroshima K, Hung YP, Kindler H, Krausz T, Marchevsky A, Mino-Kenudson M, Mueller J, Nabeshima K, Turaga K, Walts AE, Husain AN</author>
    <category>Mod Pathol</category>
    <guid isPermaLink="false">PubMed:33060816</guid>
</item>
</channel>
</rss>
